S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Bargain in Today's Market (SHOCKING) (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Bargain in Today's Market (SHOCKING) (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Bargain in Today's Market (SHOCKING) (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
Bargain in Today's Market (SHOCKING) (Ad)pixel
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
LON:MDC

Mediclinic International - MDC Share Forecast, Price & News

GBX 497.60
-1.00 (-0.20%)
(As of 08/9/2022 06:20 AM ET)
Add
Compare
Today's Range
497.20
500.50
50-Day Range
389.40
500.50
52-Week Range
271.40
502
Volume
167,975 shs
Average Volume
1.66 million shs
Market Capitalization
£3.67 billion
P/E Ratio
2,369.52
Dividend Yield
1.20%
Price Target
GBX 421.33

Mediclinic International MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
15.5% Downside
GBX 421.33 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.18mentions of Mediclinic International in the last 14 days
Based on 5 Articles This Week
Insider Trading
Acquiring Shares
£7.32 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.17 out of 5 stars

MDC stock logo

About Mediclinic International (LON:MDC) Stock

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.

Mediclinic International Stock Performance

Shares of MDC Stock opened at GBX 498.40 ($6.02) on Tuesday. The company has a debt-to-equity ratio of 79.85, a current ratio of 1.79 and a quick ratio of 1.60. The stock has a market cap of £3.67 billion and a PE ratio of 2,371.43. The stock has a 50-day moving average of GBX 457.36 and a 200-day moving average of GBX 388.54. Mediclinic International has a one year low of GBX 271.40 ($3.28) and a one year high of GBX 502 ($6.07).

Mediclinic International Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Friday, August 26th. Stockholders of record on Thursday, August 4th will be issued a GBX 3 ($0.04) dividend. This represents a dividend yield of 0.85%. The ex-dividend date of this dividend is Thursday, August 4th.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. Berenberg Bank reaffirmed a "hold" rating and issued a GBX 464 ($5.61) price objective on shares of Mediclinic International in a research note on Thursday, August 4th. Barclays lifted their target price on shares of Mediclinic International from GBX 385 ($4.65) to GBX 460 ($5.56) and gave the company an "overweight" rating in a research note on Tuesday, May 31st.

Insider Activity

In other Mediclinic International news, insider Tom Singer purchased 20,000 shares of the company's stock in a transaction that occurred on Wednesday, May 25th. The shares were acquired at an average price of GBX 366 ($4.42) per share, for a total transaction of £73,200 ($88,448.53).

Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mediclinic International and its competitors with MarketBeat's FREE daily newsletter.

MDC Stock News Headlines

Form 8.3 - Mediclinic International plc
Why Mediclinic International's (LON:MDC) CEO Pay Matters
See More Headlines
Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mediclinic International and its competitors with MarketBeat's FREE daily newsletter.

MDC Company Calendar

Ex-Dividend for 8/26 Dividend
8/04/2022
Today
8/09/2022
Dividend Payable
8/26/2022

Industry, Sector and Symbol

Industry
Medical Care
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
30,470
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 421.33
High Stock Price Forecast
GBX 464
Low Stock Price Forecast
GBX 340
Forecasted Upside/Downside
-15.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£3.23 billion
Cash Flow
GBX 73.05 per share
Book Value
GBX 421.40 per share

Miscellaneous

Free Float
N/A
Market Cap
£3.67 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Dr. Carel Aron van der Merwe D.A. (SA) (Age 59)
    F.C.A. (SA), M.B.Ch.B., Group CEO & Exec. Director
    Comp: $1.37M
  • Mr. Petrus Jurgens Myburgh (Age 47)
    Group CFO & Exec. Director
    Comp: $918k
  • Mr. Koert H. S. Pretorius B.Compt (Age 59)
    MBL, Group Chief Operating Officer
  • Dr. Dirk C. Le Roux (Age 62)
    Group Chief Information Officer
  • Mr. James Arnold
    Head of Investor Relations
  • Mr. Gert C. Hattingh B.Acc. (Hons) (Age 57)
    CA(SA), Group Chief Governance Officer
  • Mr. Biren Valodia
    Chief Marketing Officer of Medi-Clinic Southern Africa
  • Ms. Clara Findlay
    Chief Legal Officer of Medicalinic Southern Africa
  • Mr. Wimpie Aucamp
    Chief Operating Officer of Medi-Clinic for Southern Africa
  • Mr. David J. Hadley (Age 48)
    Chief Exec. Officer of Medicalinic Middle East













MDC Stock - Frequently Asked Questions

Should I buy or sell Mediclinic International stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MDC shares.
View MDC analyst ratings
or view top-rated stocks.

What is Mediclinic International's stock price forecast for 2022?

3 Wall Street analysts have issued 12 month target prices for Mediclinic International's stock. Their MDC share price forecasts range from GBX 340 to GBX 464. On average, they predict the company's stock price to reach GBX 421.33 in the next twelve months. This suggests that the stock has a possible downside of 15.3%.
View analysts price targets for MDC
or view top-rated stocks among Wall Street analysts.

How has Mediclinic International's stock performed in 2022?

Mediclinic International's stock was trading at GBX 320.40 at the beginning of 2022. Since then, MDC shares have increased by 55.3% and is now trading at GBX 497.60.
View the best growth stocks for 2022 here
.

How often does Mediclinic International pay dividends? What is the dividend yield for Mediclinic International?

Mediclinic International declared a dividend on Wednesday, May 25th. Investors of record on Thursday, August 4th will be paid a dividend of GBX 3 per share on Friday, August 26th. This represents a dividend yield of 0.85%. The ex-dividend date of this dividend is Thursday, August 4th. The official announcement can be accessed at this link.
Read our dividend analysis for MDC
.

What other stocks do shareholders of Mediclinic International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), Rdi Reit (RDI), British American Tobacco (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO).

What is Mediclinic International's stock symbol?

Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC."

How do I buy shares of Mediclinic International?

Shares of MDC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Mediclinic International's stock price today?

One share of MDC stock can currently be purchased for approximately GBX 497.60.

How much money does Mediclinic International make?

Mediclinic International (LON:MDC) has a market capitalization of £3.67 billion and generates £3.23 billion in revenue each year.

How many employees does Mediclinic International have?

Mediclinic International employs 30,470 workers across the globe.

How can I contact Mediclinic International?

Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The official website for the company is www.mediclinic.com. The company can be reached via phone at +44-20-79549600.

This page (LON:MDC) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.